ERBB3 and breast cancer: For the UBC-TAM Series (Fig. 3a) univariate analysis, favorable prognostic associations for breast-cancer-specific survival (BCSS) were detected for non-silent mutations in MAP3K1, ERBB3, XBP1, and PIK3CA (Fig. 3b, Supplementary Data 6).